PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentRegulating IVF and embryo research: Balancing clarity with flexibility

BioNews

Regulating IVF and embryo research: Balancing clarity with flexibility

Published 18 June 2009 posted in Comment and appears in BioNews 412

Author

James Lawford Davies

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

I will miss the UK's Human Fertilisation and Embryology (HFE) 1990 Act when it is gone. I am no great supporter of our regulatory model and the 1990 Act is flawed and idiosyncratic. However, if you are going to regulate IVF and embryo research, ours is a reasonably solid regulatory...

I will miss the UK's Human Fertilisation and Embryology (HFE) 1990 Act when it is gone. I am no great supporter of our regulatory model and the 1990 Act is flawed and idiosyncratic. However, if you are going to regulate IVF and embryo research, ours is a reasonably solid regulatory framework to adopt and, although it may not always have seemed so during the last 16 years, its approach to regulation is relatively straightforward. It uses a broad, simplistic working definition of 'embryos' and offers a compromise on their use: you can create them, use them, and destroy them - but only with permission and under supervision.  

The supervisor in this case is of course the Human Fertilisation and Embryology Authority, the HFEA. It is partly because of their conduct in licensing treatment and research under the 1990 Act that we see a notable shift away from the simplicity of the 1990 Act in the style and content of the draft Human Tissue and Embryos Bill currently being scrutinised in Parliament.


A clear example of this shift is apparent in relation to PGD. The 1990 Act does not specifically address the testing and selection of embryos, but litigation has helped clarify that it does fall within the HFEA's remit and can be licensed. However, the HFEA faced widespread criticism for agreeing to license PGD for tissue typing (to allow couples to give birth to 'saviour siblings', who can donate tissue-matched cord blood stem cells to sick children) - not because the outcome was ethically unacceptable, but because such an important decision was being made by the HFEA without recourse to Parliament or the wider public. It was therefore unsurprising that the consultation document on the review of the 1990 Act stated that 'the Government believes that there is a general desire for the law to be clearer on this matter, and hence for Parliament to define some limits or criteria that apply to testing of embryos'. The draft Bill therefore includes a list of specific criteria and restrictions for PGD, tissue typing and sex selection.


Does this provide clarity? In the short term, yes. Whether one agrees or disagrees with the provisions, they provide a degree of certainty about what is licensable by the HFEA. However, detailed statutory provisions of this kind are a mixed blessing. In my view, the 1990 Act survived all of its legal challenges because it was phrased in general terms which allowed new technologies to be accommodated (albeit sometimes rather tenuously). The more prescriptive the primary legislation, the less flexibility there is to accommodate future developments and the greater the opportunity for legal challenge in the longer term.

This is not the only area where we see a change in the approach of the legislation when compared to that of the 1990 Act. Whilst the Act is largely general in its terms, the draft Bill addresses a number of particular treatments and research techniques - mainly those which have attracted controversy or debate during recent months. For example, a new category of embryo, the 'inter-species embryo' is created, and the potential benefits of mitochondrial disease research are recognised through provisions which allow for the creation of embryos using healthy mitochondria in the future. However, both techniques are subject to an important qualification: they will require the Government pass further legislation before they can be used. These regulation-making powers are common tools in statutory drafting but the powers may never in fact be applied.

There are other areas in which even a regulation-making power has been deemed unacceptable. The draft Bill prohibits certain specific techniques such as social sex selection and the use of artificial gamete. In its consultation document on the review of the 1990 Act, the Government stated that 'the development of artificial gametes...would, in theory, enable the alleviation of infertility problems for persons in certain circumstances, such as where a man is unable to produce his own sperm'. This indeed is the focus of ongoing research at my own University, yet the consultation goes on to recommend that the use of any such gametes be prohibited. It further states that 'The Government has considered whether such a ban on the use of artificial gametes should be capable of being removed through secondary legislation (that is by a regulation-making power)...The Government has decided, on balance, not to recommend such a power, proposing instead that this would be a matter requiring primary legislation'. No further reasons for this decision are given.

Like the Harry Potter books, the HFEA's Code of Practice gets longer with each new edition. The clinical and scientific judgment of those working in assisted reproduction and related research is increasingly controlled and restricted through such guidance, and now we see draft legislation which promises to turn much of what used to be in the Code into law. I am not attracted to this shift towards a greater level of detail and specificity which is apparent in the draft Bill. In addition to the diminished flexibility and risk of challenge, it also signals a move away from the already limited discretion and independence of the Authority's licensing function - in the context of a Bill which does plenty more to dilute the expertise of the Authority and transfer power to the Executive. Likewise, if we are going to adhere to this model of licensing and regulation, why restrict the application of techniques through the use of regulation-making hurdles and prohibitions? If the HFEA is capable of granting treatment and research licences for the wide range of existing techniques, surely it is also capable of determining applications for hybrid and mitochondrial disease research, or the use of artificial gametes in the future.

Related Articles

PET BioNews
Comment
18 June 2009 • 4 minutes read

Reproducing regulation: new laws for fertility treatment and embryo research - will we get it right?

by Professor Marcus Pembrey

This conference (organised by the Progress Educational Trust (PET), held at the Institute of Child Health, London on 1 November) was extremely timely, given that the new Human Fertilisation and Embryology (HFE) Bill revising regulation of assisted reproduction and embryo research was published last week. This Bill is intended to...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
18 June 2009 • 3 minutes read

The Human Tissue and Embryos Bill: a chance for further debate

by Mark Hamilton

Last week saw the publication of the UK parliamentary report of the Joint Committee on the Human Tissue and Embryos (Draft) Bill. The government is now tasked to respond over the next two months in time for the Bill to be included in the Queen's Speech in November. Certain key...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
9 June 2009 • 3 minutes read

New Human Fertilisation and Embryology Bill published in UK

by Dr Kirsty Horsey

A new Human Fertilisation and Embryology Bill was published last week by the UK's Department of Health. The Bill is designed to update and reform the existing laws on assisted conception and human embryo research in the UK, established by the 1990 Human Fertilisation and Embryology...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Inherited cancer test results and insurance premiums

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Recent
4 July 2022 • 4 minutes read

Widening the debate about direct-to-consumer genetic testing and donor conception

4 July 2022 • 3 minutes read

Join PET and Genomics England to celebrate the 200th birthday of Gregor Mendel

27 June 2022 • 4 minutes read

Thirty years of PET: our 'Fertility, Genomics and Embryo Research' report

27 June 2022 • 5 minutes read

Children's rights and donor conception: What next?

20 June 2022 • 4 minutes read

The problems with lifting donor anonymity earlier

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856